Oscar Health transitions Joel Klein to Senior Advisor; appoints new Chief Legal Officer

Oscar Health, Inc.

Joel Klein steps down as Chief Policy and Strategy Officer; becomes Senior Advisor to CEO effective Dec 17, 2021.
New employment agreement effective Jan 1, 2022 sets annual salary at $100,000; six months severance upon termination without cause.
Ranmali Bopitiya appointed Chief Legal Officer effective Jan 31, 2022; will lead legal, regulatory, compliance and risk functions.
Bopitiya previously served as Chief Legal Officer of Everside Health; has over 15 years of healthcare legal experience.

item 5.02 item 8.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Joel Klein

Senior Advisor to the Chief Executive Officer

OSCR · Oscar Health, Inc.

Effective: 2021-12-17
Filed: December 23, 2021, 6:59 PM ET

On December 17, 2021, Oscar Health, Inc. (the “Company”) and Joel Klein agreed that Mr. Klein would transition from his role as Chief Policy and Strategy Officer of the Company to a role as a Senior Advisor to the Chief Executive Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Joel Klein changed role as Senior Advisor to the Chief Executive Officer at Oscar Health, Inc..

Action: transitioned
Role: Senior Advisor to the Chief Executive Officer

Exact text from the filing

On December 17, 2021, Oscar Health, Inc. (the “Company”) and Joel Klein agreed that Mr. Klein would transition from his role as Chief Policy and Strategy Officer of the Company to a role as a Senior Advisor to the Chief Executive Officer.

View on SEC.gov

Oscar Health, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-366228

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.